Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Dec;94(3):452–458. doi: 10.1111/j.1365-2249.1993.tb08217.x

Adjuvant arthritis is associated with changes in the glycosylation of serum IgG1 and IgG2b.

H Yagev 1, A Frenkel 1, I R Cohen 1, A Friedman 1
PMCID: PMC1534435  PMID: 8252806

Abstract

The increased amounts of agalactosyl IgG (N-linked oligosaccharides terminating with N-acetylglucosamine (GlcNAc) in the serum of patients with rheumatoid arthritis (RA) and other chronic inflammatory diseases have suggested that agalactosyl IgG may be involved in the pathogenesis of RA. We have now evaluated the incidence of agalactosyl IgG in the Lewis rat during the course of adjuvant arthritis (AA). The modification in glycosylation of IgG was measured by means of polyclonal and monoclonal anti GlcNAc antibodies as well as by the lectin concanavalin A (Con A). The results show that Lewis rats undergo a change in serum IgG glycosylation during the course of AA. As in human RA patients, rats with AA lack terminal galactose on IgG heavy chain oligosaccharides, and the terminal GlcNAc or mannose residues are thus exposed. The degree of agalactosyl IgG was positively correlated with the incidence of disease, peaked 20 days after disease induction, and the IgG gradually reverted to the fully glycosylated form thereafter. The post-arthritic glycosylation profile was very similar to that characteristic of the naive animal. Purified IgG was shown to contain two IgG subclasses, IgG1 and IgG2b, which underwent changes in glycosylation. Western blot analysis revealed that IgG1 expressed a higher degree of terminal mannose, whereas IgG2b expressed a higher degree of terminal GlcNAc. These findings raise the question of the possible involvement of agalactosyl IgG in immune complex-mediated inflammation.

Full text

PDF
452

Images in this article

454Fig. 1
on p.454
454Fig. 2
on p.454
454Fig. 3
on p.454
455Fig. 4
on p.455
456Fig. 6
on p.456

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bahr G. M., Yousof A. M., Majeed H. A., Behbehani K., Lubani M., Parekh R. B., Dwek R. A., Rademacher T. W., Young D. B., Mehlert A. Agalactosyl IgG, antibodies to heat shock proteins, and acute rheumatic fever. Ann Rheum Dis. 1990 Jun;49(6):383–386. doi: 10.1136/ard.49.6.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cohen I. R., Holoshitz J., van Eden W., Frenkel A. T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum. 1985 Aug;28(8):841–845. doi: 10.1002/art.1780280802. [DOI] [PubMed] [Google Scholar]
  3. Dodon M. D., Quash G. A. The antigenicity of asialylated IgG: its relationship to rheumatoid factor. Immunology. 1981 Mar;42(3):401–408. [PMC free article] [PubMed] [Google Scholar]
  4. Holoshitz J., Naparstek Y., Ben-Nun A., Cohen I. R. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science. 1983 Jan 7;219(4580):56–58. doi: 10.1126/science.6336851. [DOI] [PubMed] [Google Scholar]
  5. Johnson P. M., Watkins J., Scopes P. M., Tracey B. M. Differences in serum IgG structure in health and rheumatoid disease. Circular dichroism studies. Ann Rheum Dis. 1974 Jul;33(4):366–370. doi: 10.1136/ard.33.4.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Karp D. R., Atkinson J. P., Shreffler D. C. Genetic variation in glycosylation of the fourth component of murine complement. Association with hemolytic activity. J Biol Chem. 1982 Jul 10;257(13):7330–7335. [PubMed] [Google Scholar]
  7. Malaise M. G., Franchimont P., Bouillene C., Houssier C., Mahieu P. R. Increased concanavalin A-binding capacity of immunoglobulin G purified from sera of patients with rheumatoid arthritis. Clin Exp Immunol. 1987 Jun;68(3):543–551. [PMC free article] [PubMed] [Google Scholar]
  8. Malaise M. G., Franchimont P., Houssier C., Closset J., Hennen G., Mahieu P. R. In vitro studies on the Fc-receptor function of mononuclear phagocytes in rheumatoid arthritis: relation between the Fc-receptor blockade and the concanavalin A-binding capacity of autologous immunoglobulin G. J Clin Immunol. 1986 Nov;6(6):442–456. doi: 10.1007/BF00915250. [DOI] [PubMed] [Google Scholar]
  9. McKinney M. M., Parkinson A. A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid. J Immunol Methods. 1987 Feb 11;96(2):271–278. doi: 10.1016/0022-1759(87)90324-3. [DOI] [PubMed] [Google Scholar]
  10. Mota I. IgG subclasses in animal species. Monogr Allergy. 1986;19:302–312. [PubMed] [Google Scholar]
  11. Nahm M. H., Clevinger B. L., Davie J. M. Monoclonal antibodies to streptococcal group A carbohydrate. I. A dominant idiotypic determinant is located on Vk. J Immunol. 1982 Oct;129(4):1513–1518. [PubMed] [Google Scholar]
  12. Nemazee D. A. Immune complexes can trigger specific, T cell-dependent, autoanti-IgG antibody production in mice. J Exp Med. 1985 Jan 1;161(1):242–256. doi: 10.1084/jem.161.1.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Parekh R. B., Dwek R. A., Rademacher T. W. Rheumatoid arthritis as a glycosylation disorder. Br J Rheumatol. 1988;27 (Suppl 2):162–169. doi: 10.1093/rheumatology/xxvii.suppl_2.162. [DOI] [PubMed] [Google Scholar]
  14. Parekh R. B., Dwek R. A., Sutton B. J., Fernandes D. L., Leung A., Stanworth D., Rademacher T. W., Mizuochi T., Taniguchi T., Matsuta K. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985 Aug 1;316(6027):452–457. doi: 10.1038/316452a0. [DOI] [PubMed] [Google Scholar]
  15. Parekh R. B., Roitt I. M., Isenberg D. A., Dwek R. A., Ansell B. M., Rademacher T. W. Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet. 1988 Apr 30;1(8592):966–969. doi: 10.1016/s0140-6736(88)91781-3. [DOI] [PubMed] [Google Scholar]
  16. Patel T. P., Parekh R. B., Moellering B. J., Prior C. P. Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody. Biochem J. 1992 Aug 1;285(Pt 3):839–845. doi: 10.1042/bj2850839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rademacher T. W., Dwek R. A. The role of oligosaccharides in modifying protein function. Ciba Found Symp. 1989;145:241–256. doi: 10.1002/9780470513828.ch14. [DOI] [PubMed] [Google Scholar]
  18. Rademacher T. W. Network theory of glycosylation--etiologic and pathogenic implications of changes in IgG glycoform levels in autoimmunity. Semin Cell Biol. 1991 Oct;2(5):327–337. [PubMed] [Google Scholar]
  19. Rademacher T. W., Parekh R. B., Dwek R. A. Glycobiology. Annu Rev Biochem. 1988;57:785–838. doi: 10.1146/annurev.bi.57.070188.004033. [DOI] [PubMed] [Google Scholar]
  20. Rademacher T. W., Parekh R. B., Dwek R. A., Isenberg D., Rook G., Axford J. S., Roitt I. The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis. Springer Semin Immunopathol. 1988;10(2-3):231–249. doi: 10.1007/BF01857227. [DOI] [PubMed] [Google Scholar]
  21. Rook G. A., Steele J., Rademacher T. A monoclonal antibody raised by immunising mice with group A streptococci binds to agalactosyl IgG from rheumatoid arthritis. Ann Rheum Dis. 1988 Mar;47(3):247–250. doi: 10.1136/ard.47.3.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rook G., Thompson S., Buckley M., Elson C., Brealey R., Lambert C., White T., Rademacher T. The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur J Immunol. 1991 Apr;21(4):1027–1032. doi: 10.1002/eji.1830210425. [DOI] [PubMed] [Google Scholar]
  23. Shakib F., Stanworth D. R. IgG subclass composition of rheumatoid arthritic sera and joint fluids. Ann Rheum Dis. 1976 Jun;35(3):263–266. doi: 10.1136/ard.35.3.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sumar N., Bodman K. B., Rademacher T. W., Dwek R. A., Williams P., Parekh R. B., Edge J., Rook G. A., Isenberg D. A., Hay F. C. Analysis of glycosylation changes in IgG using lectins. J Immunol Methods. 1990 Jul 20;131(1):127–136. doi: 10.1016/0022-1759(90)90242-n. [DOI] [PubMed] [Google Scholar]
  25. Turner J. R., Tartakoff A. M., Greenspan N. S. Cytologic assessment of nuclear and cytoplasmic O-linked N-acetylglucosamine distribution by using anti-streptococcal monoclonal antibodies. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5608–5612. doi: 10.1073/pnas.87.15.5608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van Eden W., Holoshitz J., Nevo Z., Frenkel A., Klajman A., Cohen I. R. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5117–5120. doi: 10.1073/pnas.82.15.5117. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES